1Mozaffarian D & Wu JH (2011) Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 58, 2047–2067.
2Zimmet P, Alberti G, Kaufman F, et al. (2007) The metabolic syndrome in children and adolescents. Lancet 369, 2059–2061.
3Eisenmann JC (2008) On the use of a continuous metabolic syndrome score in pediatric research. Cardiovasc Diabetol 7, 17.
4Morrison JA, Friedman LA, Wang P, et al. (2008) Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr 152, 201–206.
5Duncan GE, Li SM & Zhou XH (2004) Prevalence and trends of a metabolic syndrome phenotype among U.S. adolescents, 1999–2000. Diabetes Care 27, 2438–2443.
6Damsgaard CT, Schack-Nielsen L, Michaelsen KF, et al. (2006) Fish oil affects blood pressure and the plasma lipid profile in healthy Danish infants. J Nutr 136, 94–99.
7Pedersen MH, Molgaard C, Hellgren LI, et al. (2010) Effects of fish oil supplementation on markers of the metabolic syndrome. J Pediatr 157, 395–400.
8Campbell F, Dickinson HO, Critchley JA, et al. (2013) A systematic review of fish-oil supplements for the prevention and treatment of hypertension. Eur J Prev Cardiol 20, 107–120.
9Lauritzen L, Harslof LB, Hellgren LI, et al. (2011) Fish intake, erythrocyte n-3 fatty acid status and metabolic health in Danish adolescent girls and boys. Br J Nutr 107, 697–704.
10Asserhoj M, Nehammer S, Matthiessen J, et al. (2009) Maternal fish oil supplementation during lactation may adversely affect long-term blood pressure, energy intake, and physical activity of 7-year-old boys. J Nutr 139, 298–304.
11Wei MY & Jacobson TA (2011) Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis. Curr Atheroscler Rep 13, 474–483.
12Biltoft-Jensen A, Trolle E, Christensen T, et al. (2012) WebDASC: a web-based dietary assessment software for 8–11-year-old Danish children. J Hum Nutr Diet .
13Trost SG, Loprinzi PD, Moore R, et al. (2011) Comparison of accelerometer cut points for predicting activity intensity in youth. Med Sci Sports Exerc 43, 1360–1368.
14Cole TJ, Bellizzi MC, Flegal KM, et al. (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320, 1240–1243.
15Armstrong JM, Metherel AH & Stark KD (2008) Direct microwave transesterification of fingertip prick blood samples for fatty acid determinations. Lipids 43, 187–196.
16Metherel AH, Taha AY, Izadi H, et al. (2009) The application of ultrasound energy to increase lipid extraction throughput of solid matrix samples (flaxseed). Prostaglandins Leukot Essent Fatty Acids 81, 417–423.
17Friedewald WT, Levy RI & Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499–502.
18Cutfield WS, Jefferies CA, Jackson WE, et al. (2003) Evaluation of HOMA and QUICKI as measures of insulin sensitivity in prepubertal children. Pediatr Diabetes 4, 119–125.
19Hooper L, Thompson R, Harrison R, et al. (2004) Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database of Systematic Reviews, issue 4 CD003177.
20Davidson MH (2006) Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol 98, 27i–33i.
21Forsyth JS, Willatts P, Agostoni C, et al. (2003) Long chain polyunsaturated fatty acid supplementation in infant formula and blood pressure in later childhood: follow up of a randomised controlled trial. BMJ 326, 953–957.
22Drew Rockett B, Harris M & Raza Shaikh S (2012) High dose of an n-3 polyunsaturated fatty acid diet lowers activity of C57BL/6 mice. Prostaglandins Leukot Essent Fatty Acids 86, 137–140.
23Tu W, Eckert GJ, DiMeglio LA, et al. (2011) Intensified effect of adiposity on blood pressure in overweight and obese children. Hypertension 58, 818–824.
24Whelton SP, Chin A, Xin X, et al. (2002) Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 136, 493–503.
25Treuth MS, Butte NF, Adolph AL, et al. (2004) A longitudinal study of fitness and activity in girls predisposed to obesity. Med Sci Sports Exerc 36, 198–204.
26Kodas E, Galineau L, Bodard S, et al. (2004) Serotoninergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat. J Neurochem 89, 695–702.
27Takeuchi T, Fukumoto Y & Harada E (2002) Influence of a dietary n-3 fatty acid deficiency on the cerebral catecholamine contents, EEG and learning ability in rat. Behav Brain Res 131, 193–203.
28Hamazaki T, Sawazaki S, Itomura M, et al. (1996) The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study. J Clin Invest 97, 1129–1133.
29Buydens-Branchey L & Branchey M (2006) n-3 Polyunsaturated fatty acids decrease anxiety feelings in a population of substance abusers. J Clin Psychopharmacol 26, 661–665.
30Nordic Council of Ministers (2004) Nordic Nutrition Recommendations 2004. Copenhagen: Norden.
31National Food Institute (2010) Danskernes Kostvaner 2003–2008. Hovedresultater (Dietary Habits in Denmark 2003–2008. Main Results). Søborg: Rosendahls – Schultz Grafisk A/S.
32Metherel AH, Armstrong JM, Patterson AC, et al. (2009) Assessment of blood measures of n-3 polyunsaturated fatty acids with acute fish oil supplementation and washout in men and women. Prostaglandins Leukot Essent Fatty Acids 81, 23–29.
33Mozaffarian D & Wu JH (2012) (n-3) Fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary? J Nutr 142, 614S–625S.
34Burdge GC, Sala-Vila A, West AL, et al. (2007) The effect of altering the 20 : 5n-3 and 22 : 6n-3 content of a meal on the postprandial incorporation of n-3 polyunsaturated fatty acids into plasma triacylglycerol and non-esterified fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 77, 59–65.
35Andersen LB, Harro M, Sardinha LB, et al. (2006) Physical activity and clustered cardiovascular risk in children: a cross-sectional study (The European Youth Heart Study). Lancet 368, 299–304.
36Cooper GR & Bayse DD (1985) Standardization of lipid and lipoprotein determinations for pediatric screening procedures. Prog Clin Biol Res 188, 1–17.
37Olson RE (2000) Atherogenesis in children: implications for the prevention of atherosclerosis. Adv Pediatr 47, 55–78.